SCHEMBL17248338

SCHEMBL17248338

c1ccc(-c2cccc(-c3ccc4c(c3)c3ccccc3n4-c3ccc4c(c3)oc3ccccc34)c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 4/20 0.40
PLA2G4A P47712 4/20 0.40
PLA2G10 O15496 1/20 0.40
KDM4E B2RXH2 2/20 0.39
ATM Q13315 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
PTGER4 P35408 1/20 0.38
AHR P35869 2/20 0.38
MMP12 P39900 1/20 0.37
MMP13 P45452 1/20 0.37
MEN1 O00255 2/20 0.37
MAPT P10636 2/20 0.37
KMT2A Q03164 2/20 0.37
ALDH1A1 P00352 1/20 0.37
HPGD P15428 1/20 0.37
TSPO P30536 1/20 0.37
PRKDC P78527 4/20 0.36
EDNRB P24530 1/20 0.35
EDNRA P25101 1/20 0.35
NPC1 O15118 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20632577 0.99 KDM4E (0.41) PLA2G2APLA2G4APLA2G10KDM4EATM
SCHEMBL22172963 0.99 KDM4E (0.41) PLA2G2APLA2G4APLA2G10KDM4EATM
SCHEMBL22174964 0.97 ATM (0.41) PLA2G2APLA2G4APLA2G10KDM4EATM
SCHEMBL19009381 0.96 ATM (0.40) PLA2G2APLA2G4APLA2G10KDM4EATM
SCHEMBL19009388 0.96 ATM (0.40) PLA2G2APLA2G4APLA2G10KDM4EATM
SCHEMBL22174958 0.96 ATM (0.40) PLA2G2APLA2G4APLA2G10KDM4EATM
SCHEMBL17248345 0.96 KDM4E (0.45) PLA2G2APLA2G4APLA2G10KDM4EATM
SCHEMBL21485490 0.96 ATM (0.41) PLA2G2APLA2G4APLA2G10KDM4EATM
SCHEMBL17166700 0.96 PLA2G2A (0.40) PLA2G2APLA2G4APLA2G10KDM4EATM
SCHEMBL15964300 0.96 ATM (0.41) PLA2G2APLA2G4APLA2G10KDM4EATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10361378-B2 Organic electroluminescent device NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2019-07-23 US disclosed
EP-2933851-B1 ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL & SUMIKIN CHEM CO (JP) 2017-05-10 EP disclosed
US-20150325796-A1 ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2015-11-12 US disclosed
US-20150325796-A1 ORGANIC ELECTROLUMINESCENT DEVICE NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) 2015-11-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10361378-B2 Organic electroluminescent device ELF3, DDT, LEF1 PLA2G2A 4329/4885PLA2G4A 4258/4885PLA2G10 4578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.